89 Viral co-infections in SARS-CoV-2 4 Supplementary information Author Coinfections tested Patients tested (all positive for SARSCoV-2) Coinfections (%) Influenza coinfection (%) RSV coinfection (%) Adeno coinfection (%) Alosaimi (2021), Saudi Arabia AV, HCoV (NL63, HKU1, 229E, OC43), MPV, RV, Influenza, BV, PIV, RSV 48 30 (62.5) 7 (14.6) 0 (0) 10 (20.8) Bhatraju (2020), USA Influenza, RSV 23 0 (0) 0 (0) 0 (0) NA Castillo (2020), USA AV, HCoV, MPV, RV, Influenza, PIV, RSV 23 1 (4) 1 (4) 0 (0) 0 (0) Chekuri (2021), USA AV, HCoV (NL63, HKU1, 229E, OC43), MPV, RV, Influenza, PIV, RSV 306 14 (4.6) 0 (0) 1 (6.7) 1 (6.7) Chen (2020), China AV, SARSCoV-1, MERS, Influenza, PIV, RSV 99 0 (0) 0 (0) 0 (0) 0 (0) Ding (2020), China Influenza 115 5 (4.4) 5 (4.4) NA NA Drake* (2020), UK Influenza 779 138 (17.7) 138 (17.7) NA NA Kawai (2021), Japan Influenza 193 0 (0) 0 (0) NA NA Kim (2020), USA AV, HCoV (NL63, HKU1, 229E, OC43), MPV, RV, Influenza, PIV, RSV 116 25 (21.6) 1 (0.9) 6 (5.2) 0 (0)
RkJQdWJsaXNoZXIy MTk4NDMw